Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention

PLoS Medicine

Volumn 11, Issue 9, 2014, Pages

  Lönnroth, Knut ^a   Glaziou, Philippe ^a   Weil, Diana ^a   Floyd, Katherine ^a   Uplekar, Mukund ^a   Raviglione, Mario ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPTUAL FRAMEWORK; DISEASE SURVEILLANCE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; HUMAN RIGHTS; INCOME; INSURANCE; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT MONITORING; POVERTY; PROPHYLAXIS; REVIEW; RISK MANAGEMENT; SOCIAL CARE; TUBERCULOSIS; ECONOMICS; HEALTH; POLICY; TRENDS;

GLOBAL HEALTH; HEALTH EXPENDITURES; HUMANS; PUBLIC POLICY; TUBERCULOSIS; UNIVERSAL COVERAGE;

EID: 84907960403     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001693     Document Type: Review

References (62)

1. WHO Sixty-Seventh World Health Assembly (2014). Global strategy and targets for tuberculosis prevention, care and control after 2015. A67/11. Geneva: World Health Organization.
2. WHO (2013) Global tuberculosis report 2013. WHO/HTM/TB/2013.11. Geneva: World Health Organization
3. Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, et al. (2013) Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis 13: 690–697.
4. Raviglione M, Marais B, Floyd K, Lönnroth K, Getahun H, et al. (2012) Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 19: 1902–13.
5. Laxminarayan R, Klein EY, Darley S, Adeyi O, (2009) Global investments in TB control: economic benefits. Health Aff 28: 730–742.
6. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al., eds. (2006) Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press and The World Bank.
7. Floyd K, Fitzpatrick C, Pantoja A, Raviglione M, (2002) Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002—11, and requirements to meet 2015 targets. Lancet Glob Health 1: e105–e115.
8. Storla DG, Yimer S, Bjune GA, (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.
9. Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, et al. (2013) Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis 17: 381–387.
10. Ukwaja KN, Modebe O, Igwenyi C, Alobu I, (2012) The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis 16: 733–739.
11. WHO (2008) Contributing to health system strengthening - Guiding principles for national tuberculosis programmes. WHO/HTM/TB/2008.400. Geneva: World Health Organization
12. Atun R, Weil DEC, Tan Eang M, Mwakyusa D, (2010) Health-system strengthening and tuberculosis control. Lancet 19: 2169–78.
13. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K, (2014) Financial burden for tuberculosis patients in low- and middle-income countries – a systematic review. Eur Respir J 43: 1763–1775.
14. Long Q, Smith H, Zhang T, Tang S, Garner OP, (2011) Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 11: 393.
15. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, et al. (2014) Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 11: 1001675.
16. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M, (2009) Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 68: 2240–2246.
17. Storla DG, Yimer S, Bjune G A, (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.
18. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW, (2008) Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 12: 1235–1254.
19. Munro SA, Lewin SA, Smith H, Engel ME, Fretheim A, et al. (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 4: e238.
20. Waitt CJ, Squire SB, (2001) A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 15: 871–885.
21. WHO (2010) World Health Report 2010: health systems financing - the path to universal coverage. Geneva: World Health Organization
22. International Labour Office (2009) A joint Crisis Initiative of the UN Chief Executives Board for Co-ordination on the social protection floor. Geneva: International Labour Organization.
23. International Labour Office (2010) World Social Security Report 2010/11: providing coverage in times of crisis and beyond. Geneva: ILO.
24. Rockefeller Foundation, Save the Children, UNICEF, World Health Organization (2013) Universal health coverage: a commitment to close the gap. London: Save the Children
25. Volmink J, Garner P, (1997) Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 315: 1403–6.
26. Rocha C, Montoya R, Zevallos K, Curatola A, Ynga W, et al. (2011) The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis 15: S50–S57.
27. Wei X, Zou G, Yin J, Walley J, Yang H, et al. (2012) Providing financial incentives to rural-to-urban TB migrants in Shanghai: an intervention study. Infect Dis Poverty 1: 9.
28. Toczek A, Cox H, du Cros P, Cooke G, Ford N, (2012) Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 17: 299–307.
29. Sripad A, Castedo J, Danford N, Zaha R, Freile C, (2014) Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis 18: 44–48.
30. Baral SC, Aryal Y, Bhattrai R, King R, Newell JN, (2014) Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. BMC Public Health 14: 46.
31. Richter L, Lönnroth K, Desmond C, Jackson R, Jaramillo E, et al. (2014) Economic support to patients in HIV and TB grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria. PLoS ONE 9: e86225.
32. Raviglione M, Krech R, (2011) Tuberculosis: still a social disease. Int J Tuberc Lung Dis 15: S6–S8.
33. WHO (2013) Eliminating the Catastrophic Economic Burden of TB: Universal Health Coverage and Social Protection Opportunities - report of a global consultation. Geneva: World Health Organization. Available: www.who.int/tb/uhc_socialprotection/en Accessed 14 November 2013.
34. Rasanathan K, Sivasankara AK, Jaramillo E. Lönnroth K, (2011) The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis 15: S30–36.
35. WHO (2013) World health report 2013: research for universal health coverage. Geneva: World Health Organization.
36. Dye C, Maher D, Weil D, Espinal M, Raviglione M, (2006) Targets for global tuberculosis control. Int J Tuberc Lung Dis 10: 460–462.
37. Boerma T, AbouZahr C, Evans D, Evans T, (2014) Monitoring intervention coverage in the context of universal health coverage. PLoS Med 11: e1001728.
38. WHO (1994) Framework for effective tuberculosis control. WHO/TB/94.179. Geneva: World Health Organization
39. WHO (2002) An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. Geneva: World Health Organization
40. WHO (2006) Revised TB recording and reporting forms and registers—version 2006. WHO/HTM/TB/2006.373. Geneva: World Health Organization
41. Styblo K, Bumgarner JR (1991) Tuberculosis can be controlled with existing technologies: evidence. The Hague: Tuberculosis Surveillance Research Unit.
42. Dye C, Garnett GP, Sleeman K, Williams BG, (1998) Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed shortcourse therapy. Lancet 352: 1886–1891.
43. WHO (1991) Forty-fourth World Health Assembly, Resolutions and Decisions. Resolution WHA 44.8. Geneva: World Health Organization.
44. Millennium Project (2006) Goals, targets and indicators. Available: http://www.unmillenniumproject.org/goals/gti.htm. Accessed 16 October 2013.
45. WHO (2006) The Stop TB Strategy. WHO/HTM/TB/2006.368. Geneva: World Health Organization
46. WHO (2006) Engaging all health care providers in TB control - guidance on implementing public-private mix approaches. WHO/HTM/TB/2006.360. Geneva: World Health Organization
47. WHO (2003) Practical tools for involvement of private providers in TB control - A guide for NTP-managers. WHO/CDS/TB/2003.325. Geneva: World Health Organisation
48. Bassili A, Al-Hammadi A, Al-Absi A, Glaziou P, Seita A, et al. (2013) Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen. Int J Tuberc Lung Dis 17: 456–461.
49. Huseynova S, Hashim DS, Tbena MR, Harris R, Bassili A, et al. (2013) Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq. Int J Tuberc Lung Dis 17: 462–467.
50. van Leth F, van der Werf MJ, Borgdorff MW, (2008) Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule. Bull World Health Organ 86: 20–26.
51. World Health Organization (2006) The global plan to stop TB 2006–2015. Available: www.who.int/tb/features_archive/global_plan_to_stop_tb/en/index.html Accessed 14 November 2013.
52. Colijn C, Cohen T, Murray M (2006) Mathematical Models of Tuberculosis: accomplishments and future challenges. In: Proceedings of the International Symposium on Mathematical and Computational Biology. World Scientific; Manaus, Brazil, 27–30 November 2006. Available: http://www.worldscientific.com/doi/abs/10.1142/9789812708779_0008?queryID=%24%7BresultBean.queryID%7D&
53. Dye C, Bassili A, Bierrenbach A, Broekmans JF, Chadha VK, et al. (2008) Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 8: 233–243.
54. World Health Organization (2011) Tuberculosis prevalence surveys: a handbook. WHO/HTM/TB/2010.17. Geneva, World Health Organization.
55. WHO (2014) Standards and benchmarks for tuberculosis surveillance and vital registration systems: checklist and user guide. (WHO/HTM/TB/2014.02). Geneva: World Health Organization. Available: http://www.who.int/iris/bitstream/10665/112673/1/9789241506724_eng.pdf
56. WHO (2009) WHO guide to identifying the economic consequences of disease and injury. Geneva: World Health Organization
57. Ranson MK, (2002) Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 80: 613–621.
58. TBCTA (2011) The tool to estimate patients' costs. The Hague: Tuberculosis Coalition for Technical Assistance, U.S. Agency for International Development. Available: http://www.tbcare1.org/publications/toolbox/access. Accessed 14 November 2013.
59. WHO (2005) Addressing poverty in TB control. WHO/HTM/TB/2005.352. Geneva: World Health Organization.
60. Muniyandi M, Ramachandran R, Gopi PG, Chandrasekaran V, Subramani R, et al. (2007) The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis 11: 1042–1045.
61. Boccia D, Hargreaves J, Ayles H, Fielding K, Simwinga M, et al. (2009) Tuberculosis infection in Zambia: the association with relative wealth. Am J Trop Med Hyg 80: 1004–1011.
62. Harling G, Ehrlich R, Myer L, (2008) The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med 66: 492–505.